TEV 56261
Alternative Names: TEV-56261Latest Information Update: 30 Jun 2023
At a glance
- Originator Teva Pharmaceutical Industries
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Unspecified
Most Recent Events
- 30 Apr 2021 Preclinical trials in Unspecified in Israel (Parenteral) prior to April 2021